Your browser doesn't support javascript.
loading
Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapy.
Benet, Justin; Toffart, Anne-Claire; Brichon, Pierre-Yves; Chollier, Thibaut; Ruckly, Stéphane; Villa, Julie; Emprou, Camille; Pierret, Thomas; Dumas, Isabelle; Ferretti, Gilbert; Moro-Sibilot, Denis; Levra, Matteo Giaj.
Afiliação
  • Benet J; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France. Electronic address: jbenet@chu-grenoble.fr.
  • Toffart AC; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France.
  • Brichon PY; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France.
  • Chollier T; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France.
  • Ruckly S; ICUREsearch, Paris, France.
  • Villa J; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France.
  • Emprou C; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France.
  • Pierret T; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France.
  • Dumas I; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France.
  • Ferretti G; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France.
  • Moro-Sibilot D; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France.
  • Levra MG; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France.
Cancer Treat Res Commun ; 30: 100508, 2022.
Article em En | MEDLINE | ID: mdl-35033834
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2022 Tipo de documento: Article